Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
09/18/2009
Trade Name:
AndroGel
Generic Name or Proper Name (*):
testosterone
Indications Studied:
Use in adolescent boys with delayed puberty
Label Changes Summary:
New safety information added to labeling including a Boxed Warning, and revisions to the Warnings and Precautions, Adverse Reactions, and Patient Counseling sections on the risk of virilization from secondary exposure of children to testosterone due to drug transfer from unwashed or uncovered application skin sites of adult males using testosterone gel products Safety and efficacy have not been established in males < 18 years
Product Labeling:
Labeling
BPCA(B):
B
Sponsor:
Unimed
Pediatric Exclusivity Granted Date:
08/22/2007
NNPS:
TRUE'
Therapeutic Category:
Androgen-anabolic steroid
-
-